Literature DB >> 16007225

Adhesion signaling by a novel mitotic substrate of src kinases.

Ami S Bhatt1, Hediye Erdjument-Bromage, Paul Tempst, Charles S Craik, Mark M Moasser.   

Abstract

Src kinases are activated and relocalize to the cytoplasm during mitosis, but their mitotic function has remained elusive. We describe here a novel mitotic substrate of src kinases. Trask (transmembrane and associated with src kinases) is a 140 kDa type I transmembrane glycoprotein unrelated to currently known protein families. Src kinases phosphorylate Trask in vitro and mediate its mitotic hyperphosphorylation in vivo. Trask associates with both yes and src, is localized to the cell membrane during interphase, and undergoes cytoplasmic relocalization during mitosis. Overexpression of Trask leads to cell rounding and a loss of adhesion phenotype. Consistent with a function in cell adhesion, Trask interacts with a number of adhesion and matrix proteins including cadherins, syndecans, and the membrane-type serine protease 1 (MT-SP1), and is proteolytically cleaved by MT-SP1. Trask is unique among cell adhesion molecules in that it is under cell cycle regulation and thus links src kinases with the mitotic regulation of cell adhesion. This suggests a potential pathway by which hyperactive src kinases in tumors can deregulate adhesion signaling and mediate the metastatic phenotype.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16007225      PMCID: PMC3023961          DOI: 10.1038/sj.onc.1208582

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  44 in total

1.  An RNA-binding protein associated with Src through its SH2 and SH3 domains in mitosis.

Authors:  S J Taylor; D Shalloway
Journal:  Nature       Date:  1994-04-28       Impact factor: 49.962

2.  Elevated c-yes tyrosine kinase activity in premalignant lesions of the colon.

Authors:  S V Peña; M F Melhem; A I Meisler; C A Cartwright
Journal:  Gastroenterology       Date:  1995-01       Impact factor: 22.682

3.  c-Yes tyrosine kinase activity in human colon carcinoma.

Authors:  J Park; A I Meisler; C A Cartwright
Journal:  Oncogene       Date:  1993-10       Impact factor: 9.867

4.  Activation of the c-Src tyrosine kinase is required for the induction of mammary tumors in transgenic mice.

Authors:  C T Guy; S K Muthuswamy; R D Cardiff; P Soriano; W J Muller
Journal:  Genes Dev       Date:  1994-01       Impact factor: 11.361

5.  DNA synthesis induced by some but not all growth factors requires Src family protein tyrosine kinases.

Authors:  S Roche; M Koegl; M V Barone; M F Roussel; S A Courtneidge
Journal:  Mol Cell Biol       Date:  1995-02       Impact factor: 4.272

6.  Src activity increases and Yes activity decreases during mitosis of human colon carcinoma cells.

Authors:  J Park; C A Cartwright
Journal:  Mol Cell Biol       Date:  1995-05       Impact factor: 4.272

7.  A target for Src in mitosis.

Authors:  S Fumagalli; N F Totty; J J Hsuan; S A Courtneidge
Journal:  Nature       Date:  1994-04-28       Impact factor: 49.962

8.  Accessibility of the c-Src SH2-domain for binding is increased during mitosis.

Authors:  S Bagrodia; A P Laudano; D Shalloway
Journal:  J Biol Chem       Date:  1994-04-08       Impact factor: 5.157

9.  Functional interaction between c-Src and its mitotic target, Sam 68.

Authors:  S J Taylor; M Anafi; T Pawson; D Shalloway
Journal:  J Biol Chem       Date:  1995-04-28       Impact factor: 5.157

10.  P62 association with RNA is regulated by tyrosine phosphorylation.

Authors:  L L Wang; S Richard; A S Shaw
Journal:  J Biol Chem       Date:  1995-02-03       Impact factor: 5.157

View more
  67 in total

1.  Phosphorylation of Trask by Src kinases inhibits integrin clustering and functions in exclusion with focal adhesion signaling.

Authors:  Danislav S Spassov; Ching Hang Wong; Natalia Sergina; Deepika Ahuja; Michael Fried; Dean Sheppard; Mark M Moasser
Journal:  Mol Cell Biol       Date:  2010-12-28       Impact factor: 4.272

Review 2.  The cutting edge: membrane-anchored serine protease activities in the pericellular microenvironment.

Authors:  Toni M Antalis; Marguerite S Buzza; Kathryn M Hodge; John D Hooper; Sarah Netzel-Arnett
Journal:  Biochem J       Date:  2010-06-15       Impact factor: 3.857

3.  CDCP1 cleavage is necessary for homodimerization-induced migration of triple-negative breast cancer.

Authors:  H J Wright; J Arulmoli; M Motazedi; L J Nelson; F S Heinemann; L A Flanagan; O V Razorenova
Journal:  Oncogene       Date:  2016-02-15       Impact factor: 9.867

4.  Serase-1B, a new splice variant of polyserase-1/TMPRSS9, activates urokinase-type plasminogen activator and the proteolytic activation is negatively regulated by glycosaminoglycans.

Authors:  Yuushi Okumura; Masaki Hayama; Etsuhisa Takahashi; Mieko Fujiuchi; Aki Shimabukuro; Mihiro Yano; Hiroshi Kido
Journal:  Biochem J       Date:  2006-12-15       Impact factor: 3.857

Review 5.  Interdependence of cell attachment and cell cycle signaling.

Authors:  Elena N Pugacheva; Fabrice Roegiers; Erica A Golemis
Journal:  Curr Opin Cell Biol       Date:  2006-08-17       Impact factor: 8.382

6.  The cell surface glycoprotein CUB domain-containing protein 1 (CDCP1) contributes to epidermal growth factor receptor-mediated cell migration.

Authors:  Ying Dong; Yaowu He; Leonore de Boer; M Sharon Stack; John W Lumley; Judith A Clements; John D Hooper
Journal:  J Biol Chem       Date:  2012-02-07       Impact factor: 5.157

7.  Trask phosphorylation defines the reverse mode of a phosphotyrosine signaling switch that underlies cell anchorage state.

Authors:  Danislav S Spassov; Ching H Wong; Mark M Moasser
Journal:  Cell Cycle       Date:  2011-04-15       Impact factor: 4.534

8.  The transmembrane src substrate Trask is an epithelial protein that signals during anchorage deprivation.

Authors:  Danislav S Spassov; Frederick L Baehner; Ching Hang Wong; Stephen McDonough; Mark M Moasser
Journal:  Am J Pathol       Date:  2009-04-06       Impact factor: 4.307

9.  CUB-domain-containing protein 1 (CDCP1) activates Src to promote melanoma metastasis.

Authors:  Hui Liu; Shao-En Ong; Kwabena Badu-Nkansah; Jeffrey Schindler; Forest M White; Richard O Hynes
Journal:  Proc Natl Acad Sci U S A       Date:  2011-01-10       Impact factor: 11.205

10.  Trask loss enhances tumorigenic growth by liberating integrin signaling and growth factor receptor cross-talk in unanchored cells.

Authors:  Danislav S Spassov; Ching Hang Wong; Sunny Y Wong; Jeremy F Reiter; Mark M Moasser
Journal:  Cancer Res       Date:  2012-12-12       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.